Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
80 results
  1. Search Strategies - Supplemental Project to Assess the Transparency of Reporting Requirements: Omega-3 Fatty Acids and .... 
    https://www.ncbi.nlm.nih.gov/books/NBK475903
    ... tx, kw, ct, sh, bt, id, cc] 7. Docosahexaenoic Acids/ 8. docosahexa?noic.mp. [mp=ti, ab, ot, ... an, tx, sh, ct, bt, id, cc] 7. Docosahexaenoic Acids/ 8. docosahexa?noic.mp. [mp=ti, ot, ab, ...
  2. Key Question 4: Supplements Versus Placebo for Cognition, Function, and Quality of Life - Diagnosis and Treatment of ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556562
    ... were community dwelling. One trial used capsules with docosahexaenoic acid (430 mg) and eicosapentaenoic acid (150 mg). 318 , ... trial used capsules of fish oil concentrate with docosahexaenoic acid (675 mg) and eicosapentaenoic acid (975 mg). 320 ...
  3. List of Excluded Studies - Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update ... 
    https://www.ncbi.nlm.nih.gov/books/NBK564739
    ... Matsuoka Y, Nishi D, Hamazaki K, et al. Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among ... BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: ...
  4. Excluded Studies - Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: Groundwork for a ... 
    https://www.ncbi.nlm.nih.gov/books/NBK541632
    ... Matsuoka Y, Nishi D, Hamazaki K, et al. Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among ... BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: ...
  5. List of Excluded Studies - Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2023 Update ... 
    https://www.ncbi.nlm.nih.gov/books/NBK595091
    ... Matsuoka Y, Nishi D, Hamazaki K, et al. Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among ... BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: ...
  6. Included Studies List - Screening for Lipid Disorders in Children and Adolescents: An Evidence Update for the U.S. ... 
    https://www.ncbi.nlm.nih.gov/books/NBK593594
    ... Engler MB, Malloy MJ, et al. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY ... Engler MM, Engler MB, Arterburn LM, et al. Docosahexaenoic acid supplementation alters plasma phospholipid fatty acid composition in ...
  7. Nutraceutical Interventions - Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and ... 
    https://www.ncbi.nlm.nih.gov/books/NBK442432
    ... D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer’ ... Lee LK, Shahar S, Chin AV, et al. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild ...
  8. List of Included Studies - Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. ... 
    https://www.ncbi.nlm.nih.gov/books/NBK554655
    ... Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a ... D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers ...
  9. Excluded studies - Cystic Fibrosis - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK535663
    ... Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: ... S. D., The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - ...
  10. List of Included Studies - ADHD Diagnosis and Treatment in Children and Adolescents - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK603006
    ... F, et al. Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity ... A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · next · last